Stock Information
Summit Therapeutics Inc (SMMT)
Ticker Symbol: SMMT
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $11,863.20 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -1.6038
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -291.24%
Latest News
-
Arcus: 'Buy' On Casdatifan Late-Stage CcRCC Advancement And 1st-Line Expansions
Fri, Jul 24, 2026 3:32 PM
-
Alpha Buying: When a CEO Spends $5 Million on His Own Stock, Pay Attention
Fri, Jul 24, 2026 3:29 PM
-
Summit Therapeutics Flags Going Concern Risk Over Cash Needs
Fri, Jul 24, 2026 11:53 AM
-
Stifel Maintains Buy on Summit Therapeutics, Lowers Price Target to $38
Fri, Jul 24, 2026 10:46 AM
-
Guggenheim Maintains Buy on Summit Therapeutics, Lowers Price Target to $38
Fri, Jul 24, 2026 9:52 AM
-
Deckers Outdoor, Summit Therapeutics, Robert Half And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
Fri, Jul 24, 2026 8:04 AM
-
Summit Therapeutics (SMMT) Reports In-Line Q2 Loss; Stock Eases Amid Pivotal PDUFA Catalyst
Thu, Jul 23, 2026 11:27 PM
-
Summit Therapeutics Inc. (SMMT) Q2 2026 Earnings Call Transcript
Thu, Jul 23, 2026 10:40 PM
-
Summit Therapeutics Inc. 2026 Q2 - Results - Earnings Call Presentation
Thu, Jul 23, 2026 6:31 PM
-
Summit Therapeutics Plans To Offer $380M Common Shares
Thu, Jul 23, 2026 4:39 PM
Key Financials
Financial data not available